78 related articles for article (PubMed ID: 23726596)
1. Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation.
Mazanowska O; Kamińska D; Krajewska M; Banasik M; Zabińska M; Kościelska-Kasprzak K; Biecek P; Chudoba P; Patrzałek D; Boratyńska M; Klinger M
Transplant Proc; 2013 May; 45(4):1458-61. PubMed ID: 23726596
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury.
Mazanowska O; Kamińska D; Krajewska M; Zabińska M; Kopeć W; Boratyńska M; Chudoba P; Patrzalek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):3000-3. PubMed ID: 21996210
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients.
Mazanowska O; Zabińska M; Kościelska-Kasprzak K; Kamińska D; Krajewska M; Banasik M; Madziarska K; Zmonarski SC; Chudoba P; Biecek P; Boratyńska M; Klinger M
Transplant Proc; 2014 Oct; 46(8):2636-9. PubMed ID: 25380883
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation.
Hirt-Minkowski P; Marti HP; Hönger G; Grandgirard D; Leib SL; Amico P; Schaub S
Transpl Immunol; 2014 Jan; 30(1):1-6. PubMed ID: 24291496
[TBL] [Abstract][Full Text] [Related]
5. Advanced age of renal transplant recipients correlates with increased plasma concentrations of interleukin-6, chemokine ligand 2 (CCL2), and matrix metalloproteinase 2, and urine concentrations of CCL2 and tissue inhibitor of metalloproteinase 1.
Mazanowska O; Zabińska M; Kościelska-Kasprzak K; Kamińska D; Banasik M; Krajewska M; Madziarska K; Zmonarski SC; Chudoba P; Biecek P; Boratyńska M; Klinger M
Transplant Proc; 2014 Oct; 46(8):2640-3. PubMed ID: 25380884
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(2):88-93. PubMed ID: 19886183
[TBL] [Abstract][Full Text] [Related]
7. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
Mühl D; Nagy B; Woth G; Falusi B; Bogár L; Weber G; Lantos J
J Crit Care; 2011 Dec; 26(6):550-5. PubMed ID: 21530151
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction.
Kelly D; Squire IB; Khan SQ; Dhillon O; Narayan H; Ng KH; Quinn P; Davies JE; Ng LL
Am J Cardiol; 2010 Aug; 106(4):477-82. PubMed ID: 20691304
[TBL] [Abstract][Full Text] [Related]
10. [Expression of MMP-2 and TIMP-1 in renal tissues of patients with chronic active antibody-mediated renal graft rejection].
Wang BY; Yan Q; Zou HQ; Sui WG; Zuo GM; Liang GR; Luo H; Xie SY; Chen HZ; Xie SP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2048-51. PubMed ID: 22200710
[TBL] [Abstract][Full Text] [Related]
11. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
[TBL] [Abstract][Full Text] [Related]
13. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
15. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
Nicholson ML; Waller JR; Bicknell GR
Br J Surg; 2002 Jul; 89(7):933-7. PubMed ID: 12081746
[TBL] [Abstract][Full Text] [Related]
16. [Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux].
Taranta-Janusz K; Zoch-Zwierz W; Wasilewska A; Tenderenda E; Korzeniecka-Kozerska A
Pol Merkur Lekarski; 2010 Aug; 29(170):88-92. PubMed ID: 20842819
[TBL] [Abstract][Full Text] [Related]
17. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
[TBL] [Abstract][Full Text] [Related]
19. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
20. Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation.
Kwiatkowska E; Domanski L; Bober J; Safranow K; Romanowski M; Pawlik A; Kwiatkowski S; Ciechanowski K
Kidney Blood Press Res; 2016; 41(3):288-97. PubMed ID: 27160811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
